scholarly article | Q13442814 |
P2093 | author name string | F. Orskov | |
I. Orskov | |||
A. Ferencz | |||
P2860 | cites work | A mucoprotein derived from human urine which reacts with influenza, mumps, and Newcastle disease viruses | Q24647479 |
Comparison of Escherichia coli fimbrial antigen F7 with type 1 fimbriae | Q33899933 | ||
Adherence of Escherichia coli to human mucosal cells mediated by mannose receptors | Q34170765 | ||
Recombination and complementation between temperature-sensitive mutants of a Bunyavirus, snowshoe hare virus | Q40629789 | ||
The isolation and estimation of urinary mucoproteins | Q42123027 | ||
Non-flagellar filamentous appendages (fimbriae) and haemagglutinating activity in Bacterium coli | Q64452449 | ||
Gordil | Q5584716 | ||
P433 | issue | 8173 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | Escherichia coli | Q25419 |
P304 | page(s) | 887 | |
P577 | publication date | 1980-04-19 | |
P1433 | published in | The Lancet | Q939416 |
P1476 | title | Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli | |
P478 | volume | 1 |
Q54501700 | A comparative study of the mannose-resistant and mannose-sensitive haemagglutinins of Escherichia coli isolated from urinary tract infections. |
Q73978812 | A rat model with an isolated bladder in situ |
Q44453713 | Ability of uropathogens to bind to Tamm Horsfall protein-coated renal tubular cells. |
Q70415578 | Acute human pyelonephritis: leukocytic infiltration of tubules and localization of bacteria |
Q64451736 | Adherence of Gram-Negative Uropathogens to Human Uroepithelial Cells |
Q40612733 | Adhesion of piliated Escherichia coli strains to phagocytes: differences between bacteria with mannose-sensitive pili and those with mannose-resistant pili |
Q36989708 | Adhesion-dependent activation of mucosal interleukin-6 production |
Q44364491 | Analysis of an expanded width of albumin fraction by cellulose acetate membrane electrophoresis in IgA nephropathy urine before treatment. |
Q36931660 | Antimicrobial mechanisms of the urinary tract. |
Q40084687 | Bacterial Adherence to Cell Surface Sugars |
Q64451411 | Bacterial adherence |
Q54722843 | Bacterial adherence in urinary tract infections: preliminary studies in a primate model. |
Q35383033 | Binding of type 1-piliated Escherichia coli to vaginal mucus. |
Q34237921 | Catheter-associated infections: pathogenesis affects prevention |
Q36505260 | Cell surface hydrophobicity, adherence to HeLa cell cultures and haemagglutination pattern of pyelonephritogenic Escherichia coli strains |
Q39830217 | Characterization of Shigella type 1 fimbriae: expression, FimA sequence, and phase variation. |
Q35664578 | Characterization of a recurrent in-frame UMOD indel mutation causing late-onset autosomal dominant end-stage renal failure |
Q37055410 | Common themes in microbial pathogenicity |
Q35506768 | Decreased expression of mannose-specific adhesins by Escherichia coli in the colonic microflora of immunoglobulin A-deficient individuals. |
Q70748552 | Deoxyribonucleic acid is a significant component of the small-intestinal mucus |
Q37030620 | Effect of Tamm-Horsfall urinary glycoprotein on phagocytosis and killing of type I-fimbriated Escherichia coli. |
Q34118565 | Effect of uropathogens on in vitro encrustation of polyurethane double J ureteral stents. |
Q40614602 | Escherichia coli adhesion to Saccharomyces cerevisiae and mammalian cells: role of piliation and surface hydrophobicity |
Q36250298 | Escherichia coli in extra-intestinal infections |
Q69434298 | Excretion of urinary Tamm-Horsfall glycoprotein in girls with recurrent urinary tract infections |
Q37223130 | Expression of type 1 fimbriae may be required for persistence of Escherichia coli in the catheterized urinary tract. |
Q40613654 | F7 and type 1-like fimbriae from three Escherichia coli strains isolated from urinary tract infections: protein chemical and immunological aspects |
Q36956647 | Fimbriation, capsulation, and iron-scavenging systems of Klebsiella strains associated with human urinary tract infection |
Q36965100 | Frequency and organization of papA homologous DNA sequences among uropathogenic digalactoside-binding Escherichia coli strains |
Q34575791 | Gal-Gal pili vaccines prevent pyelonephritis by piliated Escherichia coli in a murine model. Single-component Gal-Gal pili vaccines prevent pyelonephritis by homologous and heterologous piliated E. coli strains |
Q37900471 | Genetics of innate immunity and UTI susceptibility. |
Q35112094 | Hepatitis viruses: changing patterns of human disease |
Q36482861 | Hints to the diagnosis of uromodulin kidney disease. |
Q45006534 | Host defense within the urinary tract. I. Bacterial adhesion initiates an uroepithelial defense mechanism |
Q36999836 | Identification of factors in human urine that inhibit the binding of Escherichia coli adhesins |
Q37032785 | Immunochemical characterization of P pili from invasive Escherichia coli. |
Q34112294 | In defense of the bladder |
Q37011999 | Interaction of a 60-kilodalton D-mannose-containing salivary glycoprotein with type 1 fimbriae of Escherichia coli |
Q40182527 | Isolation and characterization of Escherichia coli pili from diverse clinical sources. |
Q40184109 | Isolation and characterization of F12 adhesive fimbrial antigen from uropathogenic Escherichia coli strains |
Q46560161 | Microbial biofilm formation and catheter-associated bacteriuria in patients with suprapubic catheterisation |
Q36703997 | Microbial colonization of human ileal conduits |
Q36429470 | Modified method for studying bacterial adhesion to isolated uroepithelial cells and uromucoid. |
Q34528446 | Molecular basis of Escherichia coli colonization of the upper urinary tract in BALB/c mice. Gal-Gal pili immunization prevents Escherichia coli pyelonephritis in the BALB/c mouse model of human pyelonephritis |
Q31115599 | Molecular cloning and characterization of a novel carboxylesterase-like protein that is physiologically present at high concentrations in the urine of domestic cats (Felis catus). |
Q37030193 | Monoclonal antibodies against the nonhemagglutinating fimbrial antigen 1C (pseudotype 1) of Escherichia coli |
Q36452846 | N-Glycans carried by Tamm-Horsfall glycoprotein have a crucial role in the defense against urinary tract diseases |
Q39751651 | Pathogenic factors in recurrent urinary tract infections and renal scar formation in children |
Q64452221 | Pili Mediated Agglutination ofSerratia marcescensin Human Urine |
Q38036647 | Prophylaxis of infection-induced kidney stone formation |
Q28360014 | Protection against Escherichia coli-induced urinary tract infections with hybridoma antibodies directed against type 1 fimbriae or complementary D-mannose receptors |
Q54703063 | Reduction in the anti-adherence activity of Tamm-Horsfall protein with increasing concentration of calcium. |
Q37626554 | Serum uromodulin is associated with impaired glucose metabolism. |
Q37983470 | Susceptibility to acute pyelonephritis or asymptomatic bacteriuria: host-pathogen interaction in urinary tract infections |
Q33554449 | Synthetic peptides corresponding to protective epitopes of Escherichia coli digalactoside-binding pilin prevent infection in a murine pyelonephritis model |
Q33748345 | Tamm-Horsfall Glycoprotein Interacts with Renal Outer Medullary Potassium Channel ROMK2 and Regulates Its Function |
Q71564759 | Tamm-Horsfall glycoprotein in streptozotocin diabetic rats: a study of kidney in situ hybridization, immunohistochemistry, and urinary excretion |
Q35547804 | Tamm-Horsfall glycoprotein: biology and clinical relevance |
Q34420788 | Tamm-Horsfall protein facilitates catheter associated urinary tract infection |
Q45135282 | Tamm-Horsfall protein-mRNA synthesis is localized to the thick ascending limb of Henle's loop in rat kidney |
Q58826947 | The interaction of Tamm-Horsfall protein with the extracellular matrix |
Q30987287 | The molecular study of bacterial virulence: a review of current approaches, illustrated by the study of adhesion in uropathogenic Escherichia coli |
Q37643400 | Type 1 fimbriae contribute to catheter-associated urinary tract infections caused by Escherichia coli |
Q64451855 | Urinary Tract Infection: New Information Concerning Pathogenesis and Management |
Q39060028 | Urinary Uromodulin and Risk of Urinary Tract Infections: The Cardiovascular Health Study |
Q44877359 | Urinary tract glycoprotein: distribution and antigenic specificity |
Q35208090 | Urinary tract infections in the 90s: Pathogenesis and management |
Q33613902 | Waging war against uropathogenic Escherichia coli: winning back the urinary tract |
Search more.